Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BLTE compared with GMAB: revenue, margins and what each company keeps, and the suppliers and customers both name
BLTE
Belite Bio, Inc
Change
Mkt cap
Revenue
Revenue
GMAB
Genmab A/S
Change
Mkt cap
Revenue
Revenue
vs
Compare
BLTE
Belite Bio, Inc
vs
GMAB
Genmab A/S
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
BLTE: latest quarter not drawable. GMAB: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only BLTE
1
—
The Trustees of Columbia University in the City of New York
unlisted
supplier
Shared
0
No shared counterparties.
Only GMAB
1
COAG
Hemab Therapeutics
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
BLTE, solid
GMAB, dashed
BLTE
Belite Bio, Inc
Change
153.60
· pre 153.59
· delayed
Mkt cap
$6.0B
GMAB
Genmab A/S
Change
54.93
· pre 54.99
· delayed
Pre-market
Nov 2 '26
delayed
Mkt cap
$36.7B
vs
Compare
Pre-market
Nov 2 '26
delayed
BLTE
Belite Bio, Inc
vs
GMAB
Genmab A/S
153.60
pre 153.59
delayed
Price
54.93
pre 54.99
delayed
$6.0B
Mkt cap
$36.7B
Change
Change
BLTE
153.60
vs
GMAB
54.93
Pre-market
Nov 2 '26
delayed